Although ARF expression is known to be elevated in bladder cancer, as a consequence of p53 loss-of-function, the INK4a/ARF locus has been found to be amplified and associated with poor survival in several cases of muscle-invasive bladder cancer (MIBC) [144]. Here, CDKN2A is linked to urinary bladder carcinoma.